Certified by Founder
Lodge
Phialogics - The immune tolerance company
start up
Germany
- Frankfurt, Hesse
- 08/05/2023
- Pre-Seed
- $662,970
Our immune checkpoint activators protect patient’s organ tissue.
Unique approach :
- Potential for BEST-in-class super agonist against immune-mediated tissue damage
- High selectivity for active T-cells
- Proof of concept in relevant human in vitro models and mouse model of disease
- Industry Biotechnology Research
- Website https://www.phialogics.com/
- LinkedIn https://www.linkedin.com/company/phialogics/
Related People
Andreas ErnstFounder
Germany -
ND
Expert in protein engineering with a keen interest in drug development for the treatment of autoimmune diseases.
SavvyMoney | $225,000,000 | (Oct 28, 2025)
Paygentic | $2,000,000 | (Oct 28, 2025)
Honey Health | $7,800,000 | (Oct 28, 2025)
Natural | $9,800,000 | (Oct 28, 2025)
PodPlay Technologies | $8,000,000 | (Oct 28, 2025)
Seneca | $60,000,000 | (Oct 28, 2025)
Serval | $47,000,000 | (Oct 28, 2025)
Bridge | $5,100,000 | (Oct 28, 2025)
Vermeer | $10,000,000 | (Oct 24, 2025)
GammaTime | $14,000,000 | (Oct 24, 2025)
Apriority Financial, Inc. | $2,300,000 | (Oct 24, 2025)
GradBridge | $20,000,000 | (Oct 24, 2025)